Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Single-cell omics industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Application trends
2.1.5 End-user trends
Chapter 3 Single-cell Omics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing adoption of personalized medicine
3.2.1.2 Increasing R&D spending by biopharmaceutical and biotechnology companies
3.2.1.3 Technological advancements in single-cell analysis products
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of single-cell analysis
3.2.2.2 Issues associated with data security and privacy
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By application
3.3.3 By end-user
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Single-cell Omics Market, By Product Type, 2018 - 2032 (USD Million)
5.1 Key trends, by product type
5.2 Single-cell genomics
5.3 Single-cell proteomics
5.4 Single-cell metabolomics
5.5 Single-cell transcriptomics
Chapter 6 Single-cell Omics Market, By Application, 2018 - 2032 (USD Million)
6.1 Key trends, by application
6.2 Oncology
6.3 Cell biology
6.4 Neurology
6.5 Immunology
6.6 Other applications
Chapter 7 Single-cell Omics Market, By End-user, 2018 - 2032 (USD Million)
7.1 Key trends, by end-user
7.2 Academic and research organizations
7.3 Pharmaceutical & biotechnology companies
7.4 Hospital and diagnostic laboratories
7.5 Other end-users
Chapter 8 Single-cell Omics Market, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 CYTENA GmbH
9.2 10x Genomics
9.3 BD
9.4 CELLENION
9.5 PerkinElmer Inc.
9.6 ANGLE plc
9.7 Illumina, Inc
9.8 Bio-Rad Laboratories, Inc.
9.9 Mission Bio
9.10 Standard BioTools Inc.
